Susceptibility to ketoconazole of Candida albicans strains from sequentially followed HIV-1 patients with recurrent oral candidosis.
The MIC values of the antifungal drug ketoconazole were evaluated on 66 Candida albicans strains. These strains were isolated from 26 HIV-1 infected patients with oral recurrent candidosis. Each episode of oral candidosis observed in these patients was orally treated with ketoconazole (200 mg/day) until the clinical disappearance of the lesions. The most frequent MIC values were 20 micrograms/ml and 10 micrograms/ml, observed in 37 and 19 isolates respectively. Only strains from five patients showed changes in their susceptibility to ketoconazole. This fact could indicate that a different strain causes the subsequent reappearance of the oral lesions, rather than the drug selecting resistant fungal strains. Our results stress the role of host characteristics in the occurrence of candidal infections, pointing to the progressing failure of the immunological response as the most important factor responsible for the recurrence of oral candidosis during HIV-1 infection.
Bruatto
M
M
Istituto di Malattie Infettive dell'Università di Torino, Italy.
Marinuzzi
G
G
Raiteri
R
R
Sinicco
A
A
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000328:Adult; D002176:Candida albicans / Q000187:drug effects*; D002180:Candidiasis, Oral / Q000188:drug therapy*; D005260:Female; D015658:HIV Infections / Q000382:microbiology; D006801:Humans; D007654:Ketoconazole / Q000627:therapeutic use*; D008297:Male; D008826:Microbial Sensitivity Tests; D012008:Recurrence
D007654:Ketoconazole